DMAC
DiaMedica Therapeutics Inc.
$6.71
-$0.09(-1.32%)
49
Overall
45
Value
60
Tech
44
Quality
Market Cap
$350.97M
Volume
223.87K
52W Range
$3.19 - $7.49
Target Price
$12.33
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | $500.0K | -- | -- | -- | -- | -- | -- | ||
| Total Revenue | $500.0K | -- | -- | -- | -- | -- | -- | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $-7.3M | $-11.6M | $12.7M | $13.6M | $14.0M | $21.3M | $26.7M | ||
| Research & Development | $4.5M | $7.9M | $8.2M | $8.8M | $7.8M | $13.1M | $19.1M | ||
| Research Expense | $4.5M | $7.9M | $8.2M | $8.8M | $7.8M | $13.1M | $19.1M | ||
| Selling, General & Administrative | $2.7M | $3.7M | $4.5M | $4.9M | $6.2M | $8.2M | $7.6M | ||
| General & Administrative Expenses | $2.7M | $3.7M | $4.5M | $4.9M | $6.2M | $8.2M | $7.6M | ||
| Salaries & Wages | $-620.0K | $-1.2M | $-1.8M | $-1.6M | $-1.5M | $-1.7M | $-2.1M | ||
| Depreciation & Amortization | $-15.0K | $-21.0K | $21.0K | $24.0K | $25.0K | $30.0K | $39.0K | ||
| Depreciation & Amortization | $-15.0K | $-21.0K | $21.0K | $24.0K | $25.0K | $30.0K | $39.0K | ||
| Other Operating Expenses | -- | $-65.0K | $66.0K | $65.0K | $78.0K | $104.0K | $104.0K | ||
| OPERATING INCOME | |||||||||
| Operating income | $-7.3M | $-11.6M | $-12.7M | $-13.6M | $-14.0M | $-21.3M | $-26.7M | ||
| EBITDA | $-5.6M | $-10.7M | $-12.5M | $-13.6M | $-14.0M | $-19.3M | $-24.4M | ||
| NON-OPERATING ITEMS | |||||||||
| Intinc | $1.2M | $856.0K | -- | -- | -- | $2.0M | $2.3M | ||
| Net Non-Operating Interest Income/Expense | $1.2M | $856.0K | -- | -- | -- | $2.0M | $2.3M | ||
| Other Income/Expense | $-393.0K | $-119.0K | $-434.0K | $-82.0K | $353.0K | $-1.9M | $-2.3M | ||
| Other Special Charges | $393.0K | $119.0K | $434.0K | $82.0K | $353.0K | $1.9M | $2.3M | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-5.7M | $-10.6M | $-12.5M | $-13.6M | $-14.0M | $-19.3M | $-24.4M | ||
| Pre-Tax Income | $-5.7M | $-10.6M | $-12.3M | $-13.6M | $-13.6M | $-19.3M | $-24.4M | ||
| INCOME TAX | |||||||||
| Tax Provision | $80.0K | $31.0K | $27.0K | $28.0K | $28.0K | $43.0K | $30.0K | ||
| NET INCOME | |||||||||
| Net Income | $-5.7M | $-10.6M | $-12.3M | $-13.6M | $-13.7M | $-19.4M | $-24.4M | ||
| Net Income (Continuing Operations) | $-5.7M | $-10.6M | $-12.3M | $-13.6M | $-13.7M | $-19.4M | $-24.4M | ||
| Net Income (Discontinued Operations) | $-5.7M | $-10.6M | $-12.3M | $-13.6M | $-13.7M | $-19.4M | $-24.4M | ||
| Net Income (Common Stockholders) | $-5.7M | $-10.6M | $-12.3M | $-13.6M | $-13.7M | $-19.4M | $-24.4M | ||
| Normalized Income | -- | -- | -- | $-10.7M | -- | -- | $-24.2M | ||
| TOTALS | |||||||||
| Total Expenses | $-7.3M | $-11.6M | $12.7M | $13.6M | $14.0M | $21.3M | $26.7M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $7.7M | $12.0M | $15.7M | $20.8M | $26.4M | $32.6M | $40.4M | ||
| Average Shares Outstanding (Diluted) | $7.7M | $12.0M | $15.7M | $20.8M | $26.4M | $32.6M | $40.4M | ||
| Shares Outstanding | $12.0M | $14.1M | $18.8M | $26.4M | $26.5M | $51.7M | $42.9M | ||
| Basic EPS | -- | -- | $-0.78 | $-0.65 | $-0.52 | $-0.60 | $-0.60 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-0.78 | $-0.65 | $-0.52 | $-0.60 | $-0.60 | ||
| Diluted EPS | $-0.74 | $-0.89 | $-0.78 | $-0.65 | $-0.52 | $-0.60 | $-0.60 | ||
| OTHER METRICS | |||||||||
| Gain On Sale Of P P E | -- | -- | $23.0K | $17.0K | $12.0K | $10.0K | $25.0K | ||
| Net Income Discontinuous Operations | $17.0K | $14.0K | -- | -- | -- | -- | -- | ||
| Other Gand A | $2.7M | $3.7M | $4.5M | $4.9M | $6.2M | $8.2M | $7.6M | ||
| Provision For Gain Loss On Disposal | $17.0K | $14.0K | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $2.7M | $3.7M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DMAC | $6.71 | -1.3% | 223.87K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get DiaMedica Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW